Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp92 | Thyroid Nodules and Cancer | ECE2019

Diagnostic performance evaluation of a computer-assisted imaging analysis system for ultrasound risk stratification of thyroid nodules

L Reverter Jordi , Puig-Jove Carlos , Vazquez Federico , Puig-Domingo Manel

Aim: To evaluate the diagnostic effectiveness of the first commercially available computer-aided diagnostic (CAD) imaging analysis system.Methods: Ultrasound images of 300 thyroid nodules (135 malignant) acquired prior to surgical treatment were retrospectively reviewed by a thyroid expert, and then the classification of each image was compared to the classification rendered by an image analysis program (AmCAD-UT®). The American Thyroid A...

ea0063p786 | Thyroid 2 | ECE2019

Long-term efficacy of percutaneous ethanol injection in symptomatic thyroid cysts: Results and protocol proposal

Vazquez Federico , Perez-Montes de Oca Alejandra , Puig-Domingo Manel , Reverter Jordi L

Aim: To evaluate the long-term efficacy of percutaneous ethanol injection treatment (PEIT) as an alternative to thyroid surgery in symptomatic thyroid cysts with a structured protocol.Methods: Seventy five subjects (48±12 years; 58% women) with symptomatic benign thyroid cysts relapsed after drainage were included. PEIT was conducted using the established procedure in our hospital, and the initial cyst volume, pain perceived by the patient and sympt...

ea0081p254 | Late-Breaking | ECE2022

Facial phenotype changes and its impact in Quality of Life of acromegaly patients

Ferrer Laura , Antonia Martinez-Momblan Maria , Marques-Pamies Montse , vazquez Federico , Soldevila Berta , Ciriza Raquel , Valassi Elena , Puig-Domingo Manel

Acromegaly is a rare disease usually diagnosed late in disease evolution. It implies for skeletal changes of most flat bones including those of the skull. Consequently, a progressive facial disfiguration occurs at slow velocity of irreversible nature. Even after curation most of these changes stay for the whole life of the patient.Aim: to study the potential relationship between disfiguring facial modifications and psychosocial and Quality of Life (QoL) ...

ea0090ep730 | Pituitary and Neuroendocrinology | ECE2023

Precision medicine in acromegaly: results of the ACROFAST study

Puig-Domingo Manel , Marques-Pamies Montserrat , Gil Joan , Valassi Elena , Gimenez-Palop Olga , Hernandez Marta , Taibo Rocio Villar , Biagetti Betina , Villarroya Gemma Xifra , Simo-Servat Andreu , Zavala Roxana , Simon Inmaculada , Araujo-Castro Marta , Centeno Rogelio Garcia , Calatayud Maria , Miguel Federico Vazquez San , Vilarrasa N , Vert Isabel Salinas , Mora Mireia , Hanzu Felicia Alexandra , Novoa Maria Paz De Miguel , Pavon Isabel , Blanco Concepcion , Alvarez-Escola Cristina , Sampedro-Nunez Miguel Antonio , Jorda Mireia , Bernabeu Ignacio , Webb Susan , Marazuela Monica

Medical treatment of acromegaly is currently performed through a trial-error manner using somatostatin receptor ligands (SRLs) as first-line drugs. Average SRLs response is seen in 50% of cases; subsequent drugs are indicated following clinical judgement. Some biomarkers either before or after surgical failure have been reported to predict SRLs response, including intensity in T2 weighted MRI, short acute octreotide test (sAOT), and different molecules such as SST2 and E-cadhe...